- Corporate Officers - P
- Peterson Amy C.
Insider Trading History of Peterson Amy C.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Peterson Amy C. since 2017.
This trader's CIK number is 1682735.
At the time of last reporting, Peterson Amy C. was the EVP Prod Dev & Med Aff & CMO of Exelixis, Inc.. (stock ticker symbol EXEL).
Also see all insider trading activities at Exelixis, Inc..
Note that in the past
Peterson Amy C. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Beigene, Ltd. (BGNE) by Peterson Amy C.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | BGNE | 0 | $0 | 65,769 | $8,498,296 | 60,000 | $1,745,998 |
| 2017 | BGNE | 0 | $0 | 3,601 | $299,059 | 0 | $0 |
Yearly summary of insider trading at Exelixis, Inc. (EXEL) by Peterson Amy C.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | EXEL | 0 | $0 | 72,776 | $3,309,124 | 40,000 | $870,000 |
Yearly summary of insider trading at Cytomx Therapeutics, Inc. (CTMX) by Peterson Amy C.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CTMX | 0 | $0 | 4,257 | $8,424 | 0 | $0 |
| 2022 | CTMX | 0 | $0 | 7,463 | $10,612 | 0 | $0 |
Insider trading activities at 3 companies by Peterson Amy C.:
1. Beigene, Ltd. (BGNE)
2. Exelixis, Inc. (EXEL)
3. Cytomx Therapeutics, Inc. (CTMX)
Table 1. Insider trading of Beigene, Ltd. (BGNE) by Peterson Amy C.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-12-17 | BGNE | Option Ex | 9,859 | 29.10 | 286,896 |
| 2018-12-18 | BGNE | Option Ex | 10,141 | 29.10 | 295,103 |
| 2018-12-17 | BGNE | Sale | 9,859 | 133.87 | 1,319,844 |
| 2018-12-18 | BGNE | Sale | 10,141 | 133.73 | 1,356,196 |
| 2018-11-12 | BGNE | Sale | 12,067 | 115.12 | 1,389,104 |
| 2018-11-08 | BGNE | Option Ex | 14,711 | 29.10 | 428,090 |
| 2018-11-09 | BGNE | Option Ex | 13,222 | 29.10 | 384,760 |
| 2018-11-08 | BGNE | Sale | 14,711 | 125.55 | 1,846,921 |
| 2018-11-09 | BGNE | Sale | 13,222 | 121.79 | 1,610,267 |
| 2018-11-12 | BGNE | Option Ex | 12,067 | 29.10 | 351,149 |
| 2018-08-23 | BGNE | Sale | 5,769 | 169.17 | 975,964 |
| 2017-11-13 | BGNE | Sale | 3,601 | 83.05 | 299,059 |
Table 2. Insider trading of Exelixis, Inc. (EXEL) by Peterson Amy C.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-16 | EXEL | Sale | 72,776 | 45.47 | 3,309,124 |
| 2025-05-16 | EXEL | Option Ex | 40,000 | 21.75 | 870,000 |
Table 3. Insider trading of Cytomx Therapeutics, Inc. (CTMX) by Peterson Amy C.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-03-16 | CTMX | Sale | 4,257 | 1.98 | 8,424 |
| 2022-07-20 | CTMX | Sale | 7,463 | 1.42 | 10,612 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Peterson Amy C.
(EVP Prod Dev & Med Aff & CMO of Exelixis, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.